Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (569)	1/25/2000 12:52:00 AM
From: chirodoc	Read Replies (1) \| Respond to of 52153

<<<<<Gee, thanks. How come I'm the lucky one? ......you have the PhD ......my MA,DC has no credibility ......60, 80, 40 i would love to see curtis

To: scaram(o)uche who wrote (569)	1/25/2000 1:23:00 AM
From: enervestor	Read Replies (1) \| Respond to of 52153

Rick: I don't have a clue about the absolute or relative valuations of those companies, but am surprised by your relative valuations. I can understand companies that get drugs approved and sell them, but understanding and valuing these companies is beyond my scope. However, I was surprised you valued INCY at 80 and HGSI at 40. I had assumed it would be the other way around. Would you please explain how you compare INCY and HGSI?